Abstract

Mean arterial blood pressure (MAP) dynamics estimation and its automated regulation could benefit the clinical and emergency resuscitation of critical patients. In order to address the variability and complexity of the MAP response of a patient to vasoactive drug infusion, a parameter-varying model with a varying time delay is considered to describe the MAP dynamics in response to drugs. The estimation of the varying parameters and the delay is performed via a Bayesian-based multiple-model square root cubature Kalman filtering approach. The estimation results validate the effectiveness of the proposed random-walk dynamics identification method using collected animal experiment data. Following the estimation algorithm, an automated drug delivery scheme to regulate the MAP response of the patient is carried out via time-delay linear parameter-varying (LPV) control techniques. In this regard, an LPV gain-scheduled output-feedback controller is designed to meet the MAP response requirements of tracking a desired reference MAP target and guarantee robustness against norm-bounded uncertainties and disturbances. In this context, parameter-dependent Lyapunov-Krasovskii functionals are used to derive sufficient conditions for the robust stabilization of a general LPV system with an arbitrarily varying time delay and the results are provided in a convex linear matrix inequality (LMI) constraint framework. Finally, to evaluate the performance of the proposed MAP regulation approach, closed-loop simulations are conducted and the results confirm the effectiveness of the proposed control method against various simulated clinical scenarios.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.